Respiratory syncytial virus (RSV) is a virus that causes infections of the lungs and respiratory tract. It's so common that most children have been infected with the virus by age 2. Respiratory syncytial (sin-SISH-ul) virus can also infect adults.
In adults and older, healthy children, the symptoms of respiratory syncytial virus are mild and typically mimic the common cold. Self-care measures are usually all that's needed to relieve any discomfort.
Infection with respiratory syncytial virus can be severe in some cases, especially in premature babies and infants with underlying health conditions. RSV can also become serious in older adults, adults with heart and lung diseases, or anyone with a very weak immune system (immunocompromised).
July 08, 2014
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed May 14, 2014.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed May 14, 2014.
- Respiratory syncytial virus infection (RSV). Centers for Disease Control and Prevention. http://www.cdc.gov/rsv. Accessed May 14, 2014.
- Understanding RSV. American Lung Association. http://www.lung.org/lung-disease/respiratory-syncytial-virus/understanding-rsv.html. Accessed May 14, 2014.
- Kliegman RM, et al. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, Pa.: Saunders Elsevier; 2011. http://www.clinicalkey.com. Accessed May 15, 2014.
- Respiratory syncytial virus infection (RSV) — Treatment. National Institute of Allergy and Infectious Diseases. http://www.niaid.nih.gov/topics/rsv/understanding/Pages/treatment.aspx. Accessed May 15, 2014.
- Barr FE, et al. Respiratory syncytial virus infection: Treatment. http://www.uptodate.com/home. Accessed May 15, 2014.
- Symptom relief. Centers for Disease Control and Prevention. http://www.cdc.gov/getsmart/antibiotic-use/symptom-relief.html. Accessed May 15, 2014.
- Policy statement — Modified recommendations for use of Palivizumab for prevention of respiratory syncytial virus infections. American Academy of Pediatrics Policy. http://aappolicy.aappublications.org. Accessed May 14, 2014.